153 related articles for article (PubMed ID: 36458507)
1. Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of testing with PEG 1500 extract.
Gaspar A; Moura AL; Cruz C; Borrego LM
Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):261-270. PubMed ID: 36458507
[No Abstract] [Full Text] [Related]
2. The Polysorbate containing AstraZeneca COVID-19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients.
Sellaturay P; Gurugama P; Harper V; Dymond T; Ewan P; Nasser S
Clin Exp Allergy; 2022 Jan; 52(1):12-17. PubMed ID: 34822190
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
[TBL] [Abstract][Full Text] [Related]
4. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
[TBL] [Abstract][Full Text] [Related]
5. Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines.
Mouri M; Imamura M; Suzuki S; Kawasaki T; Ishizaki Y; Sakurai K; Nagafuchi H; Matsumura N; Uchida M; Ando T; Yoshioka K; Ooka S; Sugihara T; Miyoshi H; Mori M; Okada T; Yamaguchi M; Kunishima H; Kato M; Kawahata K
Allergol Int; 2022 Oct; 71(4):512-519. PubMed ID: 35718709
[TBL] [Abstract][Full Text] [Related]
6. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.
Greenhawt M; Abrams EM; Shaker M; Chu DK; Khan D; Akin C; Alqurashi W; Arkwright P; Baldwin JL; Ben-Shoshan M; Bernstein J; Bingemann T; Blumchen K; Byrne A; Bognanni A; Campbell D; Campbell R; Chagla Z; Chan ES; Chan J; Comberiati P; Dribin TE; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Grayson MH; Horner CC; Hourihane J; Katelaris CH; Kim H; Kelso JM; Lang D; Ledford D; Levin M; Lieberman J; Loh R; Mack D; Mazer B; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Oppenheimer J; Perrett KP; Ramsey A; Rank M; Robertson K; Sheikh J; Spergel JM; Stukus D; Tang MLK; Tracy JM; Turner PJ; Whalen-Browne A; Wallace D; Wang J; Waserman S; Witry JK; Worm M; Vander Leek TK; Golden DBK
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3546-3567. PubMed ID: 34153517
[TBL] [Abstract][Full Text] [Related]
7. Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergy.
Troelnikov A; Perkins G; Yuson C; Ahamdie A; Balouch S; Hurtado PR; Hissaria P
J Allergy Clin Immunol; 2021 Jul; 148(1):91-95. PubMed ID: 33991580
[TBL] [Abstract][Full Text] [Related]
8. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.
Erdeljic Turk V
Clin Immunol; 2021 Jun; 227():108748. PubMed ID: 33932618
[TBL] [Abstract][Full Text] [Related]
9. Allergic reactions to coronavirus disease 2019 vaccines and addressing vaccine hesitancy: Northwell Health experience.
Kaplan B; Farzan S; Coscia G; Rosenthal DW; McInerney A; Jongco AM; Ponda P; Bonagura VR
Ann Allergy Asthma Immunol; 2022 Feb; 128(2):161-168.e1. PubMed ID: 34699968
[TBL] [Abstract][Full Text] [Related]
10. [Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions].
Özden Ş; Tepetam FM; Atik Ö
Tuberk Toraks; 2023 Jun; 71(2):166-175. PubMed ID: 37345399
[TBL] [Abstract][Full Text] [Related]
11. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
[TBL] [Abstract][Full Text] [Related]
12. Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis.
Brockow K; Mathes S; Fischer J; Volc S; Darsow U; Eberlein B; Biedermann T
Allergy; 2022 Jul; 77(7):2200-2210. PubMed ID: 34806775
[TBL] [Abstract][Full Text] [Related]
13. Case of Polyethylene Glycol Allergy Confirmed with Basophil Activation Test and Oral Challenge Successfully Immunized with SARS-CoV-2 Vaccine.
Pasali M; Taka S; Chliva C; Katoulis A; Makris M
Iran J Allergy Asthma Immunol; 2023 Sep; 22(4):409-412. PubMed ID: 37767684
[TBL] [Abstract][Full Text] [Related]
14. Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics.
Otani IM; Tsao LR; Tang M
Ann Allergy Asthma Immunol; 2022 Jul; 129(1):88-94.e1. PubMed ID: 35288274
[TBL] [Abstract][Full Text] [Related]
15. Allergy Workup in the Diagnosis of COVID-19 Vaccines-Induced Hypersensitivity Reactions and Its Impact on Vaccination.
Petrelli F; Giannini D; Pucci C; Del Corso I; Rocchi V; Dolcher MP; Pieve G; Pratesi F; Migliorini P; Puxeddu I
Int Arch Allergy Immunol; 2023; 184(1):54-62. PubMed ID: 36265449
[TBL] [Abstract][Full Text] [Related]
16. Optimizing investigation of suspected allergy to polyethylene glycols.
Bruusgaard-Mouritsen MA; Jensen BM; Poulsen LK; Duus Johansen J; Garvey LH
J Allergy Clin Immunol; 2022 Jan; 149(1):168-175.e4. PubMed ID: 34052265
[TBL] [Abstract][Full Text] [Related]
17. The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey.
Montera MC; Giordano A; Asperti C; Aruanno A; Barzaghi CE; Bignardi D; Borrelli P; Bommarito L; Busa M; Calafiore P; Carusi V; Cinquini M; Cortellini G; Cocchi R; D'Auria F; De Caro F; Demonte A; Di Leo E; Di Lizia M; Di Rienzo A; Fumagalli F; Kihlgren P; Lodi Rizzini F; Macchia D; Manzotti G; Marra AM; Mileto P; Mietta S; Montagni M; Nettis E; Nucera E; Peveri S; Pivetta D; Pirisi M; Ramirez GA; Rivolta F; Rizzi A; Savoia A; Pedicini A; Scarpa A; Zambito M; Zisa G; Yacoub MR
Eur Ann Allergy Clin Immunol; 2024 Jan; 56(1):17-25. PubMed ID: 36927838
[No Abstract] [Full Text] [Related]
18. Endotyping of IgE-Mediated Polyethylene Glycol and/or Polysorbate 80 Allergy.
Ieven T; Coorevits L; Vandebotermet M; Tuyls S; Vanneste H; Santy L; Wets D; Proost P; Frans G; Devolder D; Breynaert C; Bullens DMA; Schrijvers R
J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3146-3160. PubMed ID: 37380070
[TBL] [Abstract][Full Text] [Related]
19. Safe Administration of SARS-CoV-2 Vaccine After Desensitization to a Biologic Containing Polysorbate 80 in a Patient With Polyethylene Glycol-Induced Severe Anaphylaxis and Sensitization to Polysorbate 80.
Nin-Valencia A; Fiandor A; Lluch M; Quirce S; Caballero T; Heredia Revuelto R; González-Muñoz M; Caballero ML; Cabañas R
J Investig Allergol Clin Immunol; 2023 Apr; 33(2):151-153. PubMed ID: 35638393
[No Abstract] [Full Text] [Related]
20. Successful mRNA COVID-19 Vaccination and Colonoscopy After Oral Desensitization in a Patient With Polyethylene Glycol Allergy.
Cha B; Kwon KS; Lee HL; Kim CW
J Korean Med Sci; 2022 Aug; 37(32):e251. PubMed ID: 35971765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
